Matches in SemOpenAlex for { <https://semopenalex.org/work/W4383709886> ?p ?o ?g. }
- W4383709886 endingPage "2616" @default.
- W4383709886 startingPage "2598" @default.
- W4383709886 abstract "Despite the therapeutic advancement with chemotherapy and targeted therapy against non-small-cell lung cancer (NSCLC), most patients ultimately develop resistance to these drugs, exhibiting disease progression, metastasis, and worse prognosis. There is, therefore, a need for the development of novel multi-targeted therapies that can offer a high therapeutic index with lesser chances of drug resistance against NSCLC. In the present study, we evaluated the therapeutic potential of a novel multi-target small molecule NLOC-015A for targeted treatment of NSCLC. Our in vitro studies revealed that NLOC-015A exhibited a broad spectrum of anticancer activities against lung cancer cell line. NLOC-015A decreased the viability of H1975 and H1299 cells with respective IC50 values of 2.07±0.19 and 1.90±0.23 µm. In addition, NLOC-015A attenuated the oncogenic properties (colony formation, migratory ability, and spheroid formation) with concomitant downregulation of expression levels of epidermal growth factor receptor (EGFR)/mammalian target of rapamycin (mTOR)/AKT, nuclear factor (NF)-κB, signaling network. In addition, the stemness inhibitory effect of NLOC0-15A was accompanied by decreased expression levels of aldehyde dehydrogenase (ALDH), MYC Proto-Oncogene (C-Myc), and (sex-determining region Y)-box 2 (SOX2) in both H1975 and H1299 cell lines. Furthermore, NLOC-015A suppressed the tumor burden and increased the body weight and survival of H1975 xenograft-bearing mice. Treatment with NLOC-015A also attenuated biochemical and hematological alterations in the tumor bearing mice. Interestingly, NLOC-015A synergistically enhanced the in vitro efficacy, and therapeutic outcome of osimertinib in vivo. In addition, the toxicity of osimertinib was significantly attenuated by combination with NLOC-015A. Altogether, our findings suggested that combining osimertinib with NLOC-015 appears to be a promising way to improve osimertinib's efficacy and achieve better therapeutic results against NSCLC. We therefore suggest that NLOC-015A might represent a new candidate for treating NSCLC via acting as a multitarget inhibitor of EGFR/mTOR/NF-Κb signaling networks and efficiently compromising the oncogenic phenotype of NSCLC." @default.
- W4383709886 created "2023-07-11" @default.
- W4383709886 creator A5012557513 @default.
- W4383709886 creator A5024286315 @default.
- W4383709886 creator A5025217018 @default.
- W4383709886 creator A5064922397 @default.
- W4383709886 date "2023-01-01" @default.
- W4383709886 modified "2023-09-30" @default.
- W4383709886 title "Therapeutic potential of EGFR/mTOR/Nf-kb targeting small molecule for the treatment of non-small cell lung cancer." @default.
- W4383709886 cites W1506043065 @default.
- W4383709886 cites W1964574933 @default.
- W4383709886 cites W1971845675 @default.
- W4383709886 cites W1997947108 @default.
- W4383709886 cites W2008631520 @default.
- W4383709886 cites W2027542963 @default.
- W4383709886 cites W203184252 @default.
- W4383709886 cites W2037548073 @default.
- W4383709886 cites W2057295912 @default.
- W4383709886 cites W2077945404 @default.
- W4383709886 cites W2087312216 @default.
- W4383709886 cites W2094121335 @default.
- W4383709886 cites W2096439168 @default.
- W4383709886 cites W2099922409 @default.
- W4383709886 cites W2106787323 @default.
- W4383709886 cites W2116240218 @default.
- W4383709886 cites W2120064876 @default.
- W4383709886 cites W2132834292 @default.
- W4383709886 cites W2136715524 @default.
- W4383709886 cites W2160855995 @default.
- W4383709886 cites W2161541244 @default.
- W4383709886 cites W2167615059 @default.
- W4383709886 cites W2259949170 @default.
- W4383709886 cites W2272547341 @default.
- W4383709886 cites W2276363025 @default.
- W4383709886 cites W2315671533 @default.
- W4383709886 cites W2393905053 @default.
- W4383709886 cites W2769635882 @default.
- W4383709886 cites W2794832255 @default.
- W4383709886 cites W2795708883 @default.
- W4383709886 cites W2802506986 @default.
- W4383709886 cites W2888948162 @default.
- W4383709886 cites W2920948544 @default.
- W4383709886 cites W2927113896 @default.
- W4383709886 cites W2945297162 @default.
- W4383709886 cites W2948544932 @default.
- W4383709886 cites W2979001172 @default.
- W4383709886 cites W2996304730 @default.
- W4383709886 cites W2999452193 @default.
- W4383709886 cites W3000697749 @default.
- W4383709886 cites W3009178154 @default.
- W4383709886 cites W3034543335 @default.
- W4383709886 cites W3035735360 @default.
- W4383709886 cites W3035887644 @default.
- W4383709886 cites W303942527 @default.
- W4383709886 cites W3082544699 @default.
- W4383709886 cites W3112462024 @default.
- W4383709886 cites W3124287829 @default.
- W4383709886 cites W3128646645 @default.
- W4383709886 cites W3134317542 @default.
- W4383709886 cites W3139653404 @default.
- W4383709886 cites W3161826828 @default.
- W4383709886 cites W3164519265 @default.
- W4383709886 cites W3165143074 @default.
- W4383709886 cites W3188164399 @default.
- W4383709886 cites W3196720771 @default.
- W4383709886 cites W3199574626 @default.
- W4383709886 cites W3199575995 @default.
- W4383709886 cites W3208366055 @default.
- W4383709886 cites W3213725962 @default.
- W4383709886 cites W3214209920 @default.
- W4383709886 cites W321828952 @default.
- W4383709886 cites W4205501423 @default.
- W4383709886 cites W4229814971 @default.
- W4383709886 cites W4245177871 @default.
- W4383709886 cites W4367675057 @default.
- W4383709886 cites W595272588 @default.
- W4383709886 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37424807" @default.
- W4383709886 hasPublicationYear "2023" @default.
- W4383709886 type Work @default.
- W4383709886 citedByCount "0" @default.
- W4383709886 crossrefType "journal-article" @default.
- W4383709886 hasAuthorship W4383709886A5012557513 @default.
- W4383709886 hasAuthorship W4383709886A5024286315 @default.
- W4383709886 hasAuthorship W4383709886A5025217018 @default.
- W4383709886 hasAuthorship W4383709886A5064922397 @default.
- W4383709886 hasConcept C104317684 @default.
- W4383709886 hasConcept C121608353 @default.
- W4383709886 hasConcept C126322002 @default.
- W4383709886 hasConcept C127561419 @default.
- W4383709886 hasConcept C143998085 @default.
- W4383709886 hasConcept C150903083 @default.
- W4383709886 hasConcept C190283241 @default.
- W4383709886 hasConcept C207001950 @default.
- W4383709886 hasConcept C2776256026 @default.
- W4383709886 hasConcept C2779013556 @default.
- W4383709886 hasConcept C2779438470 @default.
- W4383709886 hasConcept C2781018059 @default.
- W4383709886 hasConcept C2781230642 @default.